These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20024536)

  • 1. Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
    Beau-Salinas F; Jonville-Béra AP; Cissoko H; Bensouda-Grimaldi L; Autret-Leca E
    Eur J Clin Pharmacol; 2010 Apr; 66(4):413-7. PubMed ID: 20024536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HT
    Whealy M; Becker WJ
    Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative aspects of triptans in treating migraine.
    Adelman JU; Lewit EJ
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J; Fité B; López-Gil A
    Headache; 2002 Feb; 42(2):93-8. PubMed ID: 12005301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Information on migraine drugs in commonly available Indian drug information sources - Whether we satisfied the community needs?
    Thangaraju P; Mahesh K; Venkatesan S
    Indian J Pharmacol; 2022; 54(3):216-220. PubMed ID: 35848693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotamine and dihydroergotamine: a review.
    Bigal ME; Tepper SJ
    Curr Pain Headache Rep; 2003 Feb; 7(1):55-62. PubMed ID: 12525272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of triptans in the management of migraine].
    Lantéri-Minet M
    CNS Drugs; 2006; 20 Spec no.1():12-23. PubMed ID: 16841523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
    Xu H; Han W; Wang J; Li M
    J Headache Pain; 2016 Dec; 17(1):113. PubMed ID: 27957624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on eletriptan in migraine.
    McCormack PL; Keating GM
    CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory-based analysis of clinical efficacy of triptans using receptor occupancy.
    Tokuoka K; Takayanagi R; Suzuki Y; Watanabe M; Kitagawa Y; Yamada Y
    J Headache Pain; 2014 Dec; 15(1):85. PubMed ID: 25488888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute management of migraine: triptans and beyond.
    Diener HC; Limmroth V
    Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding.
    Amundsen S; Nordeng H; Fuskevåg OM; Nordmo E; Sager G; Spigset O
    Basic Clin Pharmacol Toxicol; 2021 Jun; 128(6):795-804. PubMed ID: 33730376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
    Dodick DW; Sandrini G; Williams P
    CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Migraine Treatment.
    Becker WJ
    Continuum (Minneap Minn); 2015 Aug; 21(4 Headache):953-72. PubMed ID: 26252584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.